EP15 — Stopping Silent Killers: Balancing VTE and Bleeding Risk (VTE Prophylaxis) (SOP 033) episode artwork

EPISODE · Apr 22, 2026 · 14 MIN

EP15 — Stopping Silent Killers: Balancing VTE and Bleeding Risk (VTE Prophylaxis) (SOP 033)

from rescEU ICU Briefing · host rescEU EMT Project Team

Welcome to Episode 15 of the rescEU ICU Briefing! In this crucial instalment, Dr James Whitfield, our senior intensivist, and Sister Eleanor Hayes, senior ICU nurse, guide us through the vital topic of Venous Thromboembolism (VTE) Prophylaxis. We’re diving deep into SOP RESCEU/ICU/033 V1.0, understanding how to protect our most vulnerable patients in the challenging environment of a deployed ICU Specialised Care Team. In this episode, we cover: The exceptionally high risk of VTE (DVT and PE) in critically ill patients within a deployed field hospital setting. The central operational challenge: balancing thrombosis risk against bleeding risk, especially with limited resources. The role of pharmacological prophylaxis, focusing on LMWH and its operational advantages over UFH in the field. An exploration of mechanical prophylaxis, including IPC devices and graduated compression stockings (GCS), and their practical application. How SOP 033 codifies a standardised approach, emphasising mandatory risk assessment and a hierarchy of interventions. Specific patient populations where this SOP does not apply, requiring specialised management (e.g., paediatric patients). By the end of this briefing, you should be able to: Recognise the elevated VTE risk factors in ICU SCT patients. Understand the critical importance of balancing VTE and bleeding prophylaxis. Differentiate between pharmacological and mechanical prophylaxis methods. Apply the risk assessment framework outlined in SOP RESCEU/ICU/033 V1.0. Identify patient groups excluded from the standard VTE prophylaxis protocol. This podcast is designed to supplement, not replace, the official SOP. Always refer to the full, current document (RESCEU/ICU/033 V1.0) for all clinical decisions and specific operational guidance. Your professional judgement remains paramount. Please note: This podcast was created with the assistance of an AI language model to help structure and refine the content based on the provided SOP excerpt and instructions. Co-funded by the European Union.

Episode metadata supplied by the publisher feed · Published Apr 22, 2026

Embed this episode

Join Dr James Whitfield and Sister Eleanor Hayes for Episode 15 of the rescEU ICU Briefing, where they delve into the critical topic of Venous Thromboembolism (VTE) Prophylaxis. This episode explores the unique challenges of preventing VTE in a deployed field hospital, balancing the high risk of clots against the equally serious risk of bleeding. We'll unpack the strategies outlined in SOP RESCEU/ICU/033 V1.0, covering pharmacological and mechanical methods tailored for the ICU SCT. Remember, this briefing supplements, not replaces, the official SOP – always refer to the full document for clinical decisions.

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

EP15 — Stopping Silent Killers: Balancing VTE and Bleeding Risk (VTE Prophylaxis) (SOP 033)

0:00 14:59

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of rescEU ICU Briefing?

This episode is 14 minutes long.

When was this rescEU ICU Briefing episode published?

This episode was published on April 22, 2026.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this rescEU ICU Briefing episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!